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OBJECTIVES This study examined the association between carotid artery intima-media thickness (IMT),
serum sex hormone levels, and andropausal symptoms in middle-aged men.
BACKGROUND Male sex hormones may play a dual role in the pathogenesis of atherosclerosis in men by
carrying both proatherogenic and atheroprotective effects.
METHODS We studied 239 40- to 70-year-old men (mean  SD: 57  8 years) who participated in the
Turku Aging Male Study and underwent serum lipid and sex hormone measurements.
Ninety-nine men (age 58  7 years) were considered andropausal (i.e., serum testosterone
9.8 nmol/l or luteinizing hormone [LH] 6.0 U/l and testosterone in the normal range),
and in both situations, they had subjective symptoms of andropause (a high symptom score
in questionnaire). Three were excluded because of diabetes. The rest of the men (age 57 
8 years) served as controls. Carotid IMT was determined using high-resolution B-mode
ultrasound, and serum testosterone, estradiol (E2), LH, and sex hormone-binding globulin
were measured using standard immunoassays.
RESULTS Andropausal men had a higher maximal IMT compared with controls in the common carotid
(1.08 0.34 vs. 1.00 0.23, p 0.05) and in the carotid bulb (1.44 0.48 vs. 1.27 0.35,
p  0.003). Common carotid IMT correlated inversely with serum testosterone (p  0.003)
and directly with LH (p  0.006) in multivariate models adjusted for age, total cholesterol,
body mass index, blood pressure, and smoking.
CONCLUSIONS Middle-aged men with symptoms of andropause, together with absolute or compensated (as
reflected by high normal to elevated LH) testosterone deficiency, show increased carotid
IMT. These data suggest that normal testosterone levels may offer protection against the
development of atherosclerosis in middle-aged men. (J Am Coll Cardiol 2005;45:1603–8)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.052© 2005 by the American College of Cardiology Foundation
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fross-sectional observational studies have demonstrated an
nverse relationship between endogenous serum testosterone
T) levels and coronary heart disease (CHD) in males (1).
See page 1609
oreover, a decreased serum T concentration has been
hown to be associated with acute ischemic strokes, infarct
ize, and mortality (2). Nevertheless, the independent prog-
ostic value of T for the occurrence of future adverse
ardiovascular events has not been shown (3,4), and the
esults from experimental studies are contradictory. In a
ecent series of human in vitro studies, T and other
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Manuscript received August 26, 2004; revised manuscript received December 22,
004, accepted January 11, 2005.ndrogens were shown to exert several proatherogenic
ctions in males, including increased monocyte adhesion to
ndothelial cells (5), increased expression of endothelial
dhesion molecules (5), accelerated foam cell formation (6),
nd upregulation of atherosclerosis-related genes (7). Other
xperimental studies, however, have demonstrated that T
upplementation protects from atherosclerosis in castrated
holesterol-fed male rabbits (8) and in low-density lipopro-
ein (LDL) receptor-deficient male mice (9). In addition,
he antiatherogenic effects of androgens seem to be inhib-
ted by co-administration of aromatase inhibitors, implicat-
ng a critical role for the conversion of administered T to
stradiol (E2) (9).
In contrast to climacterium in women characterized by a
ore rapid and extensive decrease in ovarian function, the
orresponding decline in androgen levels in men occurs
ore gradually and variably during aging. This condition is
ermed “partial androgen deficiency of the aging male,” or
imply “andropause.” Only about 20% of 60- to 80-year-old
en display genuine hypogonadism (10). There is currently
o widely accepted normal range for serum T for aging men,
nd most previous studies have used cut-off values defined
or young adult men. The threshold value for serum total T
sed to define hypogonadism has varied in previous studies,
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Andropause and IMT May 17, 2005:1603–8ut most have used a concentration limit of 10 nmol/l,
hereas the so far hypothetical condition of subclinical
ypogonadism has been defined as elevated or high-normal
uteinizing hormone (LH) 6 U/l, together with T in the
ow-normal range (11).
Carotid intima-media thickness (IMT) is a widely ac-
epted noninvasive measure of preclinical atherosclerosis
nd an independent predictor of future adverse cardiovas-
ular and cerebrovascular events (12–15). A limited number
f previous observations have suggested that carotid IMT
ay be inversely associated with serum T levels in very
lderly men (16), in men with type II diabetes (17), and in
bese men (18). In a recent study, the serum T concentra-
ion was inversely associated with progression of carotid
therosclerosis in elderly men (19). The relationship be-
ween serum LH and carotid IMT has not been previously
tudied. To examine the hypothesis that androgen defi-
iency in aging men is a risk factor for the development of
therosclerosis, we have examined the relationship of an-
ropause with cardiovascular risk factors and carotid IMT
n a group of 239 men between 40 and 70 years of age.
ETHODS
ubjects. The population from which the subjects were
elected consisted of all 40- to 70-year-old men living in the
ity of Turku, Finland (n 28,622, year 2000). This cohort
eceived by mail a questionnaire that inquired about general
ell-being and andropausal symptoms (15,500 men re-
urned the questionnaire). The questionnaire was composed
f three parts: 1) the simplified Turku 3-Query (T3Q)
uestionnaire (20); 2) the Aging Male Symptoms (AMS)
uestionnaire (21); and 3) query of known illnesses and
edications. The T3Q Questionnaire had three questions:
) have you had weakening in tasks requiring strength; 2)
ecreased libido; or 3) depression during the last five years?
ach “yes” answer yielded one point, with a consequent
ange of scores 0 to 3. The 2,513 men who fulfilled the
riteria for significant andropausal symptoms (2 points in
3Q) were invited to have serum T and LH measurements
aken, and 1,764 (70.2%) participated. Ninety-nine men
ho fulfilled the criteria for significant andropausal symp-
oms as well as hormonal criteria of andropause (serum total
9.8 nmol/l or LH 6 U/l and T 9.8 nmol/l), had no
Abbreviations and Acronyms
AMS  Aging Male Symptoms Questionnaire
CHD  coronary heart disease
CV  coefficient of variation
E2  estradiol
HbA1c glycated hemoglobin
IMT  intima-media thickness
LDL  low-density lipoprotein
LH  luteinizing hormone
T3Q  Turku 3-Querylinical manifestations of CHD, and had not been previ- Tusly diagnosed with hypertension or diabetes were invited
nto the study. Serum glycated hemoglobin (HbA1c) was
easured in the andropause group, and three andropausal
en who had HbA1c exceeding the reference range (4.0% to
.2%) were excluded from the analyses. In addition, a pilot
ample of 140 men (200 were invited, 70% participated) of
he cohort who did not fulfill the criteria for andropause
normal T, no significant symptoms) were studied. The
estosterone cut-off limit was based on a pilot study of the
ain study population of the same age. Subjects using any
ormones, medication for erectile dysfunction, or
oumarin-type anticoagulants were excluded from the study.
The study protocol had been approved by the Joint
ommittee on Ethics of the University of Turku and the
urku University Central Hospital. All participants gave
ritten, informed consent, and the study was conducted
ccording to the declaration of Helsinki.
easurement of serum T, LH, sex hormone-binding
lobulin, and E2. Venous blood samples were drawn from
n antecubital vein in the morning (7:30 to 11:30 AM) after
n overnight fast (8 to 11 h). Serum T was measured using
oated-tube spectrophotometry (Spectria Testosterone,
rion Diagnostica, Oulunsalo, Finland). The interassay
oefficient of variation (CV) was 6.9%, and the reference
ange for men was 9.8 to 33 nmol/l. Serum LH was
easured using an immunofluorometric assay (AutoDelfia,
allac Ltd., Turku, Finland). The interassay CV of the
ethod was 4.5%, and the reference range was 1.3 to 7.7
U/l. The free androgen index was defined as 100  T/sex
ormone-binding globulin. Sex hormone-binding globulin
as measured using an immunofluorometric assay (Au-
oDelfia, Wallac Ltd., Turku, Finland), and E2 using a
pectrophotometric assay (Spectria Estradiol, Orion Diag-
ostica, Oulunsalo, Finland). The interassay CVs of these
ethods were 3.4% and 10.0%, respectively. None of the
en had serum T less than the detection limit of the assay.
erum lipids. Serum total cholesterol, high-density li-
oprotein (HDL) cholesterol, and triglyceride concentra-
ions were measured using standard enzymatic methods,
oehringer Mannheim GmbH reagents, and a fully auto-
ated analyzer (Hitachi 917; Hitachi Ltd., Tokyo, Japan).
he LDL cholesterol concentration was calculated using
he Friedewald equation (22).
ltrasound studies. All studies were performed by an
xperienced vascular sonographer who was blinded to the
linical characteristics of the participants, using an Acuson
equoia 512 mainframe (Acuson, Mountain View, California)
ith a 13.0-MHz linear-array transducer. The studies were
erformed on fasting patients between 7:30 and 9:00 AM.
o minimize external stimuli, all studies were carried out in
silent clinical research laboratory room. Blood pressure
as measured twice during the ultrasound examination
rom the nondominant arm using a sphygmomanometer.
ll studies were done following a predetermined, standard-
zed scanning protocol for the right and left carotid arteries.
he proximal part of the carotid bulb was identified, and the
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May 17, 2005:1603–8 Andropause and IMTegment of the common carotid artery 1 to 2 cm proximal to
he bulb was scanned. The image was focused on the
osterior wall, and the resolution box function was used to
agnify the arterial far wall. Two angles were used in each
ase: anterior oblique and lateral. All scans were digitally
tored for subsequent off-line analysis. Two end-diastolic
rames of the best image quality were selected and analyzed
or maximum IMT, and the average reading from these two
rames was calculated for both the right and left carotid
rteries. Moreover, the maximum IMT of the carotid bulb
egions was examined on both sides. The images were
nalyzed off-line, unaware of the individuals’ clinical details.
n our laboratory, the between-visit CV of IMT measure-
ents was 6.4%, and the between-observer CV was 5.2%
23).
tatistical methods. The results are expressed as the mean
alue  SD. Data on serum triglycerides were skewed
oward high values and were therefore analyzed after loga-
ithmic transformation. Comparisons between the groups
ere conducted by the Student t test. Univariate associa-
ions between the study variables were analyzed by calcu-
ating the Pearson’s correlation coefficients. Multivariate
nalyses were done using the stepwise linear regression
echnique. The following explanatory variables were in-
luded in the analysis: serum T, LH, total cholesterol, age,
ody mass index, systolic blood pressure, and smoking. All
tatistical analyses were performed using the SAS statistical
nalysis system (SAS Institute, Gary, North Carolina).
ESULTS
he characteristics of the study groups are shown in Table
Table 1. Characteristics of the Study Groups
C
Age (yrs)
Height (m)
Weight (kg)
Body mass index (kg/m2)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Total cholesterol (mmol/l)
LDL cholesterol (mmol/l)
HDL cholesterol (mmol/l)
Triglycerides (mmol/l)
Testosterone (nmol/l) 1
Free androgen index (no unit)
Luteinizing hormone (U/l)
Sex hormone-binding globulin (nmol/l)
Estradiol (nmol/l)
AMS score
Smokers
Maximum common carotid IMT (mm)
Maximum IMT of the carotid bulb (mm)
Common carotid diameter (mm)
Data are presented as the mean value  SD.
AMS  Heinemann’s Aging Male Symptoms; HDL and
intima-media thickness.. Andropausal men had a higher Heinemann’s Aging Male Aymptoms (AMS) score and body mass index, weighed
ore, and had lower serum LDL cholesterol and E2 (Table
). Carotid IMT was increased in andropausal men com-
ared with controls (Table 1). No other differences were
bserved between the study groups. Common carotid and
arotid bulb IMT were similar in men with absolute and
elative T deficiency (p  0.24).
The age-adjusted univariate associations between carotid
MT and risk factors are shown in Table 2. Carotid IMT
as inversely associated with serum T levels (Fig. 1) and the
DL/total cholesterol ratio and correlated positively with
H (Fig. 2), age, blood pressure, body mass index, total
holesterol, and LDL cholesterol. In the stepwise multivar-
ate regression model, the independent explanatory variables
l Men
140)
Andropausal Men
(n  96) p Value
8.1 58.3  7.3 0.13
0.06 1.79  0.07 0.70
11.6 90.3  13.8 0.004
3.1 28.6  3.9 0.001
19 146  18 0.75
11 87  10 0.34
0.85 5.53  0.85 0.15
0.74 3.40  0.77 0.04
0.35 1.38  0.36 0.24
1.05 1.66  0.89 0.39
4.66 13.00  6.16 0.001
13.6 33.8  12.3 0.003
1.20 6.94  4.77 0.001
15.5 40.9  21.4 0.13
31.5 85.1  27.5 0.005
10.9 40.8  12.9 0.001
4%) 52 (54%) 0.74
0.23 1.08  0.34 0.045
0.35 1.44  0.48 0.003
0.95 6.75  0.94 0.84
 high- and low-density lipoprotein, respectively; IMT 
able 2. Univariate and Age-Adjusted Correlates of Carotid
rtery Intima-Media Thickness in 236 Men
Maximum Carotid
IMT
(r, p value)
Maximum IMT of
Carotid Bulb
(r, p value)
ge 0.48, 0.001 0.34, 0.001
ody mass index 0.16, 0.02 0.08, 0.26
ystolic blood pressure 0.14, 0.06 0.03, 0.70
iastolic blood pressure 0.15, 0.04 0.00, 0.98
otal cholesterol 0.25, 0.001 0.13, 0.08
DL cholesterol 0.25, 0.001 0.18, 0.01
DL/total cholesterol 0.21, 0.003 0.21, 0.004
riglycerides 0.22, 0.003 0.04, 0.63
estosterone 0.17, 0.02 0.08, 0.29
ree androgen index 0.04, 0.60 0.01, 0.97
uteinizing hormone 0.20, 0.005 0.25, 0.001
ex hormone-binding
globulin
0.06, 0.37 0.05, 0.49
stradiol 0.04, 0.57 0.03, 0.67ontro
(n 
56.7 
1.78 
85.3 
27.0 
147 
88 
5.72 
3.63 
1.44 
1.54 
6.74 
39.9 
3.82 
45.4 
98.1 
33.6 
75 (5
1.00 
1.27 
6.73 bbreviations as in Table 1.
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Andropause and IMT May 17, 2005:1603–8or carotid IMT were age (maximum IMT: p  0.001;
aximum bulb IMT: p  0.001), total cholesterol (maxi-
um IMT: p 0.001; maximum bulb IMT: p 0.022), T
maximum IMT: p  0.003; maximum bulb IMT: p 
.039), LH (maximum IMT: p  0.006; maximum bulb
MT: p  0.001), and smoking (maximum IMT:
0.025).
When the group variable for andropause was included in
he multivariate model instead of T and LH, the significant
xplanatory variables for maximum common carotid IMT
ere the group variable (p  0.004), age (p  0.001), total
holesterol (p  0.001), and smoking (p  0.031). The free
ndrogen index, when substituted for T, was not associated
ith IMT in the multivariate model.
igure 1. Correlation between serum T and maximum intima-media
hickness of the carotid bulb in 236 middle-aged men.
igure 2. Correlation between serum luteinizing hormone (LH) andv
aximum intima-media thickness of the carotid bulb in 236 middle-aged
en.ISCUSSION
he present study shows that hypogonadal status (absolute
r compensated), together with a high andropausal symp-
om score, is associated with increased carotid artery IMT,
marker of subclinical atherosclerosis in middle-aged men.
oreover, serum T was inversely and serum LH directly
ssociated with carotid IMT after controlling for CHD risk
actors in the multivariate model. The latter finding brings
urther significance for the age-related increase of LH levels
s an indicator of the initial or compensated stage of
ypogonadism, as observed previously by our group (11).
The prevalence of CHD shows a consistent male to
emale ratio of 2.2 (range 1.2 to 4.5) among different
opulations, despite considerable variations in absolute rates
24). This gender difference has been assumed to be a
onsequence of atheroprotection exerted by estrogen (25),
long with detrimental effects of androgens. In contrast,
ost (1) but not all (3,26) observational studies in recent
ears have demonstrated an inverse relationship between
ndogenous serum T levels and CHD. Furthermore, the
ata from experimental studies remain inconclusive, as T
as been shown to induce both proatherogenic and anti-
therogenic effects on the vasculature (27).
Recent studies examining carotid IMT have shown an
nverse association between serum T levels in elderly men 74
o 92 years of age (16), in men with type II diabetes (17),
nd in obese men with glucose intolerance (18). Moreover,
ak et al. (28) demonstrated in a large population-based
tudy that serum T levels inversely and independently
orrelated with the presence of aortic calcified plaques and
he progression of aortic atherosclerosis. Our current find-
ngs are in line and extend the findings of these previous
tudies by demonstrating an inverse association between
erum T and IMT in middle-aged men. The causality of
his association needs to be examined in prospective studies,
ut together, the current evidence suggests that normal
ndrogen levels may protect aging men from the develop-
ent of atherosclerosis. The possible mechanisms may
nclude anti-inflammatory effects of normal physiological
evels of sex hormones, regulation of apoptosis, and promo-
ion of smooth muscle cell stability (27).
Experimental male animal studies have shown that an-
rogens reduce diet- and injury-induced atherosclerosis
27). Some studies have implicated that the beneficial effects
f T supplementation in T-deficient animal models would
e mediated via an increase in E2 levels due to conversion of
by aromatase (9). In the present study, however, serum E2
as not associated with carotid IMT. Surprisingly, serum
H levels were associated with IMT also in the multivariate
odel after controlling for serum T. There are currently no
ata indicating that common carotid artery endothelial cells
xpress LH receptors, but these receptors have been found
n the carotid rete around the pituitary in E2-pretreated
wes (29) and in human endometrial and myometrial blood
essels (30). Therefore, it should not be assumed that the
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May 17, 2005:1603–8 Andropause and IMTssociation between carotid IMT and serum LH levels is
erely a secondary reflection or epiphenomenon of in-
reased serum LH in men with absolute or relative T
eficiency. Nevertheless, the association between LH and
MT is interesting and warrants further studies to test the
otential causality of this finding.
Andropause was associated with obesity in the current
tudy. Increased fat mass is associated with increased con-
ersion of androgens to estrogens. Furthermore, obesity-
ssociated hyperleptinemia has a suppressive effect on the
ypothalamic-pituitary-gonadal axis (31). Previous studies
ave associated T deficiency (32) with central and upper-
ody obesity, and low T levels have been shown to precede
he development of obesity (33). Obesity is a risk factor for
ncreased IMT (34). However, the association between
ndropause and serum T and IMT persisted in the multi-
ariate model after controlling for body mass index.
tudy limitations. Our study has limitations. The associ-
tions between serum T, LH, and carotid atherosclerosis
ere evaluated in a cross-sectional setting. The study
ncluded a relatively limited number of subjects. However,
he findings were rather distinct, and the small sample size
s unlikely to detract from the validity of the main findings.
nstead of free T, we only measured serum total T and sex
ormone-binding globulin and calculated from these the
ree androgen index, which was used as a marker of free T
evels. The free androgen index was not associated with
MT in the multivariate model, which was not unexpected,
ecause this parameter has previously been shown to be an
nreliable estimate of free T (35). Direct measurement of
ree T using the equilibrium dialysis technique would, in
heory, provide the most reliable estimate of the biologically
ctive T concentration (35). In practice, this method is not
nly expensive and laborious but also less consistent than
he other estimates of T. Therefore, a lack of accurate
easure of serum free T concentrations may have had a
iluting effect, if any, on our findings concerning the
ssociation between serum T levels and IMT.
onclusions. Our findings demonstrate an association be-
ween serum T levels, andropause, and carotid artery IMT
n middle-aged men. These results raise the possibility that
ndividuals with andropausal symptoms, together with im-
aired sex-hormone status and increased carotid IMT,
ight benefit from T replacement therapy to decelerate the
rogression of atherosclerosis and protect from its clinical
equelae (i.e., CHD, ischemic stroke, and peripheral vascu-
ar disease). The ultrasound measurement of carotid IMT
ight provide an additional clinical tool for decision-
aking and CHD risk stratification during consideration of
aking up T supplementation in individual patients. It is,
owever, important to consider the major change in our
erception of the effects of hormone replacement therapy on
he risk of CHD in women during recent years. Despite the
act that earlier observational studies associated hormone
eplacement therapy use with a 40% to 50% reduced risk of
HD, the recent randomized clinical trials have demon-trated that hormone replacement therapy does not confer
ardiac protection and may even slightly increase the risk of
oronary events (36,37). Therefore, randomized, controlled
rials are required to establish the effects of T supplemen-
ation on the occurrence of CHD in andropausal men
efore wide scale use of these regimens can be accepted for
revention of atherosclerotic diseases.
eprint requests and correspondence: Dr. Olli T. Raitakari,
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